Ann Hanham, Director at Endocyte, holds 46.62K shares in SCYNEXIS (Ticker: SCYX), holds 7.30K shares in HTG Molecular Diagnostics (Ticker: HTGMQ), holds 2.25K shares in Endocyte (Ticker: ECYT).
What is the percentage of profitable transactions made by Ann Hanham?
The percentage of profitable transactions made by Ann Hanham is 0%.
What is the average return per transaction made by Ann Hanham?
The average return per transaction made by Ann Hanham is -29.10%.
What stocks does Ann Hanham hold?
Ann Hanham holds: ECYT, HTGMQ, SCYX, GYRE, BMTI stocks.
What was Ann Hanham’s latest transaction?
Ann Hanham latest transaction was an Uninformative Buy of ―.
What was Ann Hanham's most profitable transaction?
Ann Hanham’s most profitable transaction was an Informative Buy of SCYX stock on December 23, 2020. The return on the trade was -4.20%.
What is Ann Hanham's role in Endocyte?
Ann Hanham's role in Endocyte is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.